Dr. John Kevin Page , MD
Internal Medicine • Grapevine, TX
1631 Lancaster Dr Ste 330
Grapevine, TX 760513585
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 27, 2006; this date does not establish years in practice.
-
Published CMS data list 7,380 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J1010 — Injection, methylprednisolone acetate, 1 mg: 3,040 service units.
- 99487 — Complex chronic care management services for two or more chronic conditions: 927 service units.
- 99214 — Established patient outpatient office visit: 524 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 26 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 8,114 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Levothyroxine Sodium — 439 prescription fills, including refills.
- Atorvastatin Calcium — 294 prescription fills, including refills.
- Rosuvastatin Calcium — 280 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 138 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Grapevine, TX (2024, 24 clinicians with data). Median for this group: 771. Middle half: 471 to 1,824.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: 645. Middle half: 277 to 1,322.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 1,263 in 2020 to 7,380 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1631 Lancaster Dr Ste 330
Grapevine, TX 760513585
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Arkansas College Of Medicine
1992
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
498 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $310,585 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $246,327 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
15,866 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$410,365 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $448.47 across 23 records.
By nature of payment
- Food and Beverage: $448.47 across 23 records.
Reporting-company totals (3 largest of 10)
- Axsome Therapeutics, Inc.: $80.90 across 3 records.
- AstraZeneca Pharmaceuticals LP: $71.76 across 4 records.
- ABBVIE INC.: $60.93 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
34 years (graduated 1992)
CMS Doctors and Clinicians data list 1992 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
May accept Medicare assignment
CMS data show this clinician may accept Medicare assignment. Clinicians who do not always accept assignment can decide case by case.
Ask the office before your visit. If a clinician does not accept assignment for a service, they can charge up to 15% more than the Medicare-approved amount, and you may be asked to pay the full amount at the visit.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Page has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Page as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Grapevine and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Grapevine, TX (2024, 24 clinicians with data). Median for this group: 771. Middle half: 471 to 1,824.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: 645. Middle half: 277 to 1,322.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in Grapevine, TX (2024, 24 clinicians with data). Median for this group: $81,038. Middle half: $42,161 to $159,456.
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: $61,221. Middle half: $27,420 to $115,826.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine in Grapevine, TX (2024, 24 clinicians with data). Median for this group: $63,276. Middle half: $32,939 to $124,985.
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: $47,501. Middle half: $20,446 to $90,051.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Internal Medicine in Grapevine, TX (2024, 20 clinicians with data). Median for this group: 1,914. Middle half: 132 to 4,546.
More Part D prescriptions than 85% of clinicians listed under Internal Medicine in Texas (2024, 5,674 clinicians with data). Median for this group: 828. Middle half: 121 to 4,824.
Part D drug cost
A higher Part D drug cost than 70% of clinicians listed under Internal Medicine in Grapevine, TX (2024, 20 clinicians with data). Median for this group: $163,036. Middle half: $11,144 to $417,004.
A higher Part D drug cost than 70% of clinicians listed under Internal Medicine in Texas (2024, 5,674 clinicians with data). Median for this group: $64,859. Middle half: $4,211 to $436,775.
27 active clinicians are listed under Internal Medicine with a practice address in Grapevine, TX (9,191 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Grapevine
29.6% of these 27 clinicians have the CMS telehealth indicator.
70.4% of these 27 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 484% from 1,263 in 2020 to 7,380 in 2024.
- 2020: 1,263
- 2021: 1,233
- 2022: 1,112
- 2023: 1,703
- 2024: 7,380
-
Medicare-allowed amount
Medicare-allowed amount increased 233% from $93,365 in 2020 to $310,585 in 2024.
- 2020: $93,365
- 2021: $117,034
- 2022: $103,488
- 2023: $111,602
- 2024: $310,585
-
Paid by Medicare
Paid by Medicare increased 298% from $61,889 in 2020 to $246,327 in 2024.
- 2020: $61,889
- 2021: $79,495
- 2022: $69,072
- 2023: $87,055
- 2024: $246,327
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 24% from 6,540 in 2020 to 8,114 in 2024.
- 2020: 6,540
- 2021: 6,305
- 2022: 6,643
- 2023: 7,212
- 2024: 8,114
-
30-day fills
30-day fills increased 35% from 11,784 in 2020 to 15,866 in 2024.
- 2020: 11,784
- 2021: 11,612
- 2022: 12,132
- 2023: 13,600
- 2024: 15,866
-
Part D drug cost
Part D drug cost increased 21% from $340,119 in 2020 to $410,365 in 2024.
- 2020: $340,119
- 2021: $302,183
- 2022: $312,390
- 2023: $443,918
- 2024: $410,365
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $759.35 in 2021 to $448.47 in 2025.
- 2021: $759.35
- 2022: $609.90
- 2023: $372.29
- 2024: $471.44
- 2025: $448.47
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 23 records totaling $448.47.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $31.62 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
— | General | $27.22 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $25.46 |
| Verity Pharmaceuticals Inc. |
Food and Beverage
Cash or cash equivalent
|
Tlando | General | $24.82 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $23.82 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $22.50 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
Cologuard Collection Kit | General | $21.63 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $20.85 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
— | General | $19.97 |
| Abbott Laboratories |
Food and Beverage
In-kind items and services
|
FREESTYLE LIBRE 3 | General | $19.44 |
| Dexcom, Inc. |
Food and Beverage
In-kind items and services
|
Dexcom G6 Transmitter | General | $18.86 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $18.31 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $18.14 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $17.95 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $17.78 |
| Abbott Laboratories |
Food and Beverage
In-kind items and services
|
FREESTYLE LIBRE 3 | General | $16.44 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $15.92 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $15.57 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
OTEZLA | General | $15.42 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $14.65 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $14.52 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $13.88 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $13.70 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J1010
Injection, methylprednisolone acetate, 1 mg
|
3,040 | 63 | $1.00 | $0.12 |
|
99487
Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month
|
927 | 234 | $235.00 | $125.09 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
524 | 267 | $469.05 | $119.79 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
419 | 248 | $318.00 | $83.36 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
408 | 76 | $14.00 | $0.91 |
|
G0439
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
|
315 | 315 | $437.00 | $121.46 |
|
96372
Injection of drug or substance under skin or into muscle
|
299 | 105 | $75.00 | $13.34 |
|
99441
Telephone medical discussion with physician, 5-10 minutes
|
182 | 176 | $149.00 | $52.63 |
|
G0396
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes
|
181 | 175 | $75.01 | $32.10 |
|
G0444
Annual depression screening, 5 to 15 minutes
|
174 | 174 | $47.00 | $17.67 |
|
96160
Administration and interpretation of patient-focused health risk assessment
|
162 | 160 | $9.00 | $2.79 |
|
96130
Evaluation of psychological test, first hour
|
149 | 147 | $299.00 | $112.47 |
|
93000
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
|
138 | 135 | $50.51 | $13.44 |
|
J3420
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
|
97 | 27 | $27.00 | $1.20 |
|
99457
Management using the results of remote vital sign monitoring per calendar month, first 20 minutes
|
92 | 24 | $130.00 | $45.79 |
|
99454
Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days
|
65 | 23 | $163.00 | $44.07 |
|
J0696
Injection, ceftriaxone sodium, per 250 mg
|
36 | 26 | $32.57 | $0.43 |
|
G0008
Administration of influenza virus vaccine
|
29 | 28 | $80.31 | $31.11 |
|
90662
Influenza vaccine split virus, preservative free
|
27 | 26 | $225.00 | $81.45 |
|
J1030
Injection, methylprednisolone acetate, 40 mg
|
27 | 27 | $64.00 | $6.04 |
|
99453
Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment
|
20 | 17 | $50.00 | $18.58 |
|
99497
Advance care planning, first 30 minutes
|
16 | 15 | $217.00 | $76.78 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
15 | 15 | $729.00 | $156.65 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
14 | 14 | $106.00 | $58.58 |
|
81003
Automated urinalysis test
|
13 | 12 | $13.00 | $2.20 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 439 | 32,174 | $3,632.21 | 115 |
| Atorvastatin Calcium | Atorvastatin Calcium | 294 | 23,194 | $1,793.06 | 84 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 280 | 21,720 | $3,333.22 | 84 |
| Pantoprazole Sodium | Pantoprazole Sodium | 279 | 19,782 | $3,214.78 | 77 |
| Amlodipine Besylate | Amlodipine Besylate | 258 | 20,340 | $1,396.33 | 72 |
| Alprazolam | Alprazolam | 251 | 4,950 | $998.71 | 45 |
| Metformin Hcl | Metformin Hcl | 207 | 15,266 | $1,219.21 | 56 |
| Hydrochlorothiazide | Hydrochlorothiazide | 200 | 12,694 | $788.26 | 56 |
| Azithromycin | Azithromycin | 198 | 1,000 | $597.85 | 152 |
| Escitalopram Oxalate | Escitalopram Oxalate | 182 | 9,760 | $1,782.09 | 42 |
| Lisinopril | Lisinopril | 179 | 13,903 | $725.58 | 55 |
| Trazodone Hcl | Trazodone Hcl | 166 | 8,728 | $1,126.96 | 33 |
| Gabapentin | Gabapentin | 164 | 8,635 | $1,628.26 | 44 |
| Zolpidem Tartrate | Zolpidem Tartrate | 161 | 5,287 | $954.69 | 35 |
| Temazepam | Temazepam | 142 | 4,490 | $1,545.72 | 32 |
| Simvastatin | Simvastatin | 141 | 11,130 | $1,301.47 | 37 |
| Meloxicam | Meloxicam | 140 | 7,979 | $805.45 | 38 |
| Bupropion Xl | Bupropion Hcl | 136 | 7,018 | $2,758.64 | 35 |
| Sertraline Hcl | Sertraline Hcl | 132 | 8,180 | $1,103.24 | 30 |
| Montelukast Sodium | Montelukast Sodium | 124 | 8,581 | $594.24 | 44 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 123 | 8,747 | $1,882.58 | 33 |
| Omeprazole | Omeprazole | 113 | 8,490 | $1,339.44 | 29 |
| Tamsulosin Hcl | Tamsulosin Hcl | 105 | 7,950 | $1,655.20 | 28 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 97 | 7,140 | $2,744.36 | 26 |
| Diazepam | Diazepam | 94 | 1,405 | $476.59 | 19 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-08-24NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20050919000524
TX
0143254235
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant
Physician Assistant (Certified)
Physician Assistant
Physician Assistant
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 1631 LANCASTER DR STE 330, GRAPEVINE, TX 760513585 (Tel: 8179533420)
Registered at 9330 LBJ FWY STE 800, DALLAS, TX 752434310 (Tel: 9727925700)
NPI status registered as active in NPPES database
Registered at 1604 LANCASTER DR, GRAPEVINE, TX 76051 (Tel: 8174818661)
Registered at 1604 LANCASTER DR, GRAPEVINE, TX 76051 (Tel: 8174818661)
Recorded as JOHN PAGE, MD
Internal Medicine (license number reported to NPPES: TX K2255)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Grapevine
- Dr. Khaliq Rauf, MD
- Dr. Sanjay Patel, MD
- Dr. Arshad Quddoos, MD
- Dr. Sajida Naeem, MD
- Dr. Maricelle Sorolla Olympia, MD
- Dr. Brooks Trotter, MD
Mailing Address
9330 Lbj Fwy Ste 800
Dallas, TX 752434310
Phone: 9727925700